Christa Einspieler1, Robert Peharz2, Peter B Marschik2. 1. Research Unit Interdisciplinary Developmental Neuroscience (iDN), Institute of Physiology, Medical University of Graz, Graz, Austria. Electronic address: christa.einspieler@medunigraz.at. 2. Research Unit Interdisciplinary Developmental Neuroscience (iDN), Institute of Physiology, Medical University of Graz, Graz, Austria.
Abstract
OBJECTIVES: To describe fidgety movements (FMs), i.e., the spontaneous movement pattern that typically occurs at 3-5 months after term age, and discuss its clinical relevance. SOURCES: A comprehensive literature search was performed using the following databases: MEDLINE/PubMed, CINAHL, The Cochrane Library, Science Direct, PsycINFO, and EMBASE. The search strategy included the MeSH terms and search strings ('fidgety movement*') OR [('general movement*') AND ('three month*') OR ('3 month*')], as well as studies published on the General Movements Trust website (www.general-movements-trust.info). SUMMARY OF THE DATA: Virtually all infants develop normally if FMs are present and normal, even if their brain ultrasound findings and/or clinical histories indicate a disposition to later neurological deficits. Conversely, almost all infants who never develop FMs have a high risk for neurological deficits such as cerebral palsy, and for genetic disorders with a late onset. If FMs are normal but concurrent postural patterns are not age-adequate or the overall movement character is monotonous, cognitive and/or language skills at school age will be suboptimal. Abnormal FMs are unspecific and have a low predictive power, but occur exceedingly in infants later diagnosed with autism. CONCLUSIONS: Abnormal, absent, or sporadic FMs indicate an increased risk for later neurological dysfunction, whereas normal FMs are highly predictive of normal development, especially if they co-occur with other smooth and fluent movements. Early recognition of neurological signs facilitates early intervention. It is important to re-assure parents of infants with clinical risk factors that the neurological outcome will be adequate if FMs develop normally.
OBJECTIVES: To describe fidgety movements (FMs), i.e., the spontaneous movement pattern that typically occurs at 3-5 months after term age, and discuss its clinical relevance. SOURCES: A comprehensive literature search was performed using the following databases: MEDLINE/PubMed, CINAHL, The Cochrane Library, Science Direct, PsycINFO, and EMBASE. The search strategy included the MeSH terms and search strings ('fidgety movement*') OR [('general movement*') AND ('three month*') OR ('3 month*')], as well as studies published on the General Movements Trust website (www.general-movements-trust.info). SUMMARY OF THE DATA: Virtually all infants develop normally if FMs are present and normal, even if their brain ultrasound findings and/or clinical histories indicate a disposition to later neurological deficits. Conversely, almost all infants who never develop FMs have a high risk for neurological deficits such as cerebral palsy, and for genetic disorders with a late onset. If FMs are normal but concurrent postural patterns are not age-adequate or the overall movement character is monotonous, cognitive and/or language skills at school age will be suboptimal. Abnormal FMs are unspecific and have a low predictive power, but occur exceedingly in infants later diagnosed with autism. CONCLUSIONS: Abnormal, absent, or sporadic FMs indicate an increased risk for later neurological dysfunction, whereas normal FMs are highly predictive of normal development, especially if they co-occur with other smooth and fluent movements. Early recognition of neurological signs facilitates early intervention. It is important to re-assure parents of infants with clinical risk factors that the neurological outcome will be adequate if FMs develop normally.
Authors: Daniel Groos; Lars Adde; Sindre Aubert; Lynn Boswell; Raye-Ann de Regnier; Toril Fjørtoft; Deborah Gaebler-Spira; Andreas Haukeland; Marianne Loennecken; Michael Msall; Unn Inger Möinichen; Aurelie Pascal; Colleen Peyton; Heri Ramampiaro; Michael D Schreiber; Inger Elisabeth Silberg; Nils Thomas Songstad; Niranjan Thomas; Christine Van den Broeck; Gunn Kristin Øberg; Espen A F Ihlen; Ragnhild Støen Journal: JAMA Netw Open Date: 2022-07-01
Authors: Dafne Herrero; Christa Einspieler; Carolina Y Panvequio Aizawa; Akmer Mutlu; Hong Yang; Alice Nogolová; Jasmin Pansy; Karin Nielsen-Saines; Peter B Marschik Journal: Res Dev Disabil Date: 2017-06-03
Authors: Peter B Marschik; Florian B Pokorny; Robert Peharz; Dajie Zhang; Jonathan O'Muircheartaigh; Herbert Roeyers; Sven Bölte; Alicia J Spittle; Berndt Urlesberger; Björn Schuller; Luise Poustka; Sally Ozonoff; Franz Pernkopf; Thomas Pock; Kristiina Tammimies; Christian Enzinger; Magdalena Krieber; Iris Tomantschger; Katrin D Bartl-Pokorny; Jeff Sigafoos; Laura Roche; Gianluca Esposito; Markus Gugatschka; Karin Nielsen-Saines; Christa Einspieler; Walter E Kaufmann Journal: Curr Neurol Neurosci Rep Date: 2017-05 Impact factor: 5.081
Authors: Frederick R Carrick; Guido Pagnacco; Ahmed Hankir; Mahera Abdulrahman; Rashid Zaman; Emily R Kalambaheti; Derek A Barton; Paul E Link; Elena Oggero Journal: Front Neurol Date: 2018-07-05 Impact factor: 4.003
Authors: Espen A F Ihlen; Ragnhild Støen; Lynn Boswell; Raye-Ann de Regnier; Toril Fjørtoft; Deborah Gaebler-Spira; Cathrine Labori; Marianne C Loennecken; Michael E Msall; Unn I Möinichen; Colleen Peyton; Michael D Schreiber; Inger E Silberg; Nils T Songstad; Randi T Vågen; Gunn K Øberg; Lars Adde Journal: J Clin Med Date: 2019-12-18 Impact factor: 4.241